All filters
Abstracts
Combined COVID-19 vaccination and hepatitis C virus screening intervention for high-risk populations at a centre for addiction services in Barcelona, Spain
J. Lazarus Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Combined COVID-19 vaccination and hepatitis C virus and HIV screening intervention for high- risk populations at a mobile testing unit in Madrid, Spain
J. Lazarus Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Community perspectives on self- testing for HIV and HCV in the WHO European region
S. North Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Viral load suppression after three-year Ibalizumab treatment in a multidrug-resistant HIV-1- infected woman: Clinical experience.
I. Santos Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
CASE - HIV+ End-Stage Renal Disease Patient with Immunosuppressive Drug-Drug Interactions Received Successful Transplantation after Ibalizumab Suppressed Switch
S. Sharma Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Clinical course of AIDS with COVID-19 coinfection with prolonged SARS CoV-2 replication despite remdesivir/molnupiravir treatment.
B. Aksak-Wąs Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
A Case of IRIS Syphilis Due to Prozone Effect
Y. Rahman Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Fatal Triple – Linking Obesity, Type-2 Diabetes, and NASH - Cyrielle Caussy, MD, PhD slides
Presented at:
Innovations in NAFLD Care Workshop 2022
Slidesets
How Will Technology Evolve Delivery Methods and Formulations - Eric Andrew Appel, PhD
Presented at:
International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021
Slidesets
How Will Technology Evolve: Modification of Antibodies - Boris Juelg, MD, PhD
Presented at:
International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021
Slidesets
How to Determine the Dosing (in Different Populations/Tissues) - Edmund Capparelli, PharmD
Presented at:
International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021
Slidesets
Monoclonal Antibodies for Treatment in Hematologic Malignancies - Alison Moskowitz, MD
Presented at:
International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021
Slidesets
Monoclonal Antibodies for Treatment in Autoimmune Diseases - Karmela Kim Chan, MD
Presented at:
International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021
Slidesets
Monoclonal Antibodies for Prevention of HIV, COVID, and Ebola - Myron Cohen, MD, BS
Presented at:
International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021
Slidesets
Monoclonal Antibodies for Treatment in COVID-19 - Florence Ader, Prof, MD
Presented at:
International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021
Slidesets
Monoclonal Antibodies Against COVID-19: Targets, Development and Clinical Applications - Brigette Autran, MD, PhD
Presented at:
International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021
Meeting
Conference on Liver Disease in Africa (COLDA) 2021
9 Sep 2021 - 11 Sep 2021
Virtual Meeting
Meeting
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
14 Oct 2021 - 15 Oct 2021
Virtual Meeting